LifePoint Health Inc (NASDAQ:LPNT) – Research analysts at Oppenheimer boosted their Q1 2018 earnings estimates for LifePoint Health in a note issued to investors on Monday. Oppenheimer analyst M. Wiederhorn now forecasts that the company will post earnings of $1.13 per share for the quarter, up from their prior estimate of $0.97. Oppenheimer also issued estimates for LifePoint Health’s Q2 2018 earnings at $1.07 EPS, Q3 2018 earnings at $1.00 EPS, Q4 2018 earnings at $1.10 EPS, FY2018 earnings at $4.30 EPS, Q1 2019 earnings at $1.20 EPS, Q2 2019 earnings at $1.14 EPS, Q3 2019 earnings at $1.07 EPS, Q4 2019 earnings at $1.16 EPS and FY2019 earnings at $4.57 EPS.
LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.04). LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter last year, the business posted $1.07 EPS. LifePoint Health’s quarterly revenue was down 7.2% compared to the same quarter last year.
Shares of LifePoint Health (NASDAQ LPNT) opened at $46.80 on Tuesday. The company has a quick ratio of 1.49, a current ratio of 1.70 and a debt-to-equity ratio of 1.26. LifePoint Health has a 12 month low of $41.45 and a 12 month high of $67.95. The stock has a market capitalization of $1,685.03, a PE ratio of 19.02, a PEG ratio of 0.98 and a beta of 0.52.
In related news, insider David M. Dill sold 45,000 shares of the stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total value of $2,183,400.00. Following the completion of the transaction, the insider now owns 252,673 shares of the company’s stock, valued at $12,259,693.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 8.76% of the company’s stock.
Large investors have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp lifted its holdings in LifePoint Health by 28.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 795,233 shares of the company’s stock worth $46,044,000 after buying an additional 177,329 shares during the last quarter. Convergence Investment Partners LLC bought a new position in LifePoint Health during the 3rd quarter worth approximately $811,000. Stevens Capital Management LP bought a new position in LifePoint Health during the 3rd quarter worth approximately $1,395,000. New York State Common Retirement Fund lifted its holdings in LifePoint Health by 3.2% during the 3rd quarter. New York State Common Retirement Fund now owns 84,969 shares of the company’s stock worth $4,920,000 after buying an additional 2,669 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in LifePoint Health by 26.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 132,589 shares of the company’s stock worth $7,757,000 after buying an additional 27,726 shares during the last quarter.
TRADEMARK VIOLATION WARNING: “Q1 2018 Earnings Forecast for LifePoint Health Inc Issued By Oppenheimer (LPNT)” was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3226892/q1-2018-earnings-forecast-for-lifepoint-health-inc-issued-by-oppenheimer-lpnt.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.